Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity

By sjmartinez • September 20, 2024

Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity. Obes Rev. 2024 Sep 19:e13841. doi: 10.1111/obr.13841. Epub ahead of print. PMID: 39295512.

Tags: Clinical Nutrition, GLP‐1 receptor agonist, Hospitalist, muscle loss, Nutrition, Publications, resistance training, Veterans Administration

Colonic goblet cell-associated antigen passages mediate physiologic and beneficial translocation of live gut bacteria in preweaning mice

Udayan S, Floyd AN, John V, Barrios BE, Rusconi BA, McDonald KG, Schill EM, Kulkarni DH, Martin AL, Gutierrez R, Talati KB, Harris DL, Sundas[...]

Reframing Micronutrient Deficiencies for Modern times: A Review

Lankarani-Fard A, Romanova M, Li Z. Reframing Micronutrient Deficiencies for Modern times: A Review. J Gen Intern Med. 2025 Mar 31. doi: 10.1007/s11606-025-09481-y. Epub ahead[...]

CRE25-032: Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma

Bransky NP, Kathuria-Prakash N, Sehl M. CRE25-032: Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CRE25-032. doi: 10.6004/jnccn.2024.7101. PMID: 40154331.